Status:
TERMINATED
Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs
Lead Sponsor:
University of Parma
Conditions:
Coagulation, Blood
Compression Devices, Intermittent Pneumatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to assess possible alteration in coagulation (blood clotting) following treatment with sequential compression devices (SCD) plus low-molecular weight heparin (LMWH) as opposed to LMWH ...
Detailed Description
Low molecular weight heparins (LMWH) are routinely used in perioperative prophylaxis of thromboembolic complications \[(chiefly deep vein thrombosis (DVT)\]. LMWHs have been proved to be safe and equi...
Eligibility Criteria
Inclusion
- Elective major abdominal surgery for neoplasm
- Planned admission to postsurgical ICU due to the patient's meeting one or more of the following:
- ASA Physical Status Class 4
- Surgery of modified Johns-Hopkins class ≥IV
- ASA 3 with modified Johns-Hopkins class 3 surgery
- Expected duration of surgery ≥8 h
Exclusion
- History of coagulation abnormalities, either congenital or acquired
- Ongoing treatment with anticoagulants/antiplatelet agents other than LMWH or hormones
- Massive edema of the legs
- Severe peripheral arteriopathy or neuropathy
- Malformations or recent surgery/trauma to the lower extremities
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00726570
Start Date
August 1 2008
End Date
November 1 2010
Last Update
November 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital / Azienda Ospedaliero-Universitaria
Parma, PR, Italy, 43100